Alfentanil-induced activation: A promising tool in the presurgical evaluation of temporal lobe epilepsy patients

Brain Research Reviews

Volumn 32, Issue 1, 2000, Pages 316-327

  Ragazzo, Paulo César ^a   Galanopoulou, Aristea S ^b  

^a Instituto de Neurologia de Goiania   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Alfentanil; Electrographic seizure; Presurgical evaluation; Temporal lobe epilepsy

Indexed keywords

ALFENTANIL; FENTANYL; METHOHEXITAL;

ADOLESCENT; ADULT; AGED; DRUG ACTIVATION; DRUG EFFECT; ELECTROCORTICOGRAPHY; EPILEPTIC FOCUS; EPILEPTOGENESIS; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SHORT SURVEY; TEMPORAL LOBE EPILEPSY;

EID: 0034031187     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00098-3     Document Type: Review

References (78)

1. Adler M.W., Lin C.H., Keinath S.H.et al. Anticonvulsant action of acute morphine administration in rats. J. Pharmacol. Exp. Ther. 198:1976;655-660.
2. C. Ajmone-Marsan, Electrocorticography. Historical comments on its development and the evolution of its practical applications, in: L.F. Quesney, C.D. Binnie, G.-E. Chatrian (Eds.), Electrocorticography: Current Trends and Future Perspectives, Elsevier, 1998, pp. 9-16.
3. T.L. Babb, W.J. Brown, Pathological findings in epilepsy, in: R. Press (Ed.), Surgical Treatment of the Epilepsies, Raven Press, NY, 1987, pp. 511-540.
4. Babb T.L., Kupfer W.R., Pretorius J.X., Crandall P.H., Levesque M.F. Synaptic reorganization by mossy fiber in human epileptic fascia dentata. Neuroscience. 42:1991;351-363.
5. Baraka A., Haroun S. Grand mal seizures following fentanyl-lidocaine. Anesthesiology. 62(2):1985;206.
6. Bausch S.B., Esteb T.M., Terman G.W., Chavkin C. Administered and endogenously released kappa opioids decrease pilocarpine-induced seizures and seizure-induced histopathology. J. Pharmacol. Exp. Ther. 284(3):1998;1147-1155.
7. Bloom F.E. The endorphins: a growing family of pharmacologically pertinent peptides. Annu. Rev. Pharmacol. 23:1983;151-170.
8. Bovill J.G., Sebel P.S., Wauquier A., Rog P., Schuyt H.C. Influence of high-dose alfentanil anaesthesia on the electroencephalogram: correlation with plasma concentrations. Br. J. Anaesthesiol. 55:1983;109S-199S.
9. Brockhaus A., Lehnertz K., Wienbruch C., Kowalik A., Burr W., Elbert T., Hoke M., Elger C.E. Possibilities and limitations of magnetic source imaging of methohexital-induced epileptiform patterns in temporal lobe epilepsy patients. Electroencephalogr. Clin. Neurophysiol. 102:1997;423-436.
10. G.D. Cascino, Pharmacological activation, in: L.F. Quesney, C.D. Binnie, G.-E. Chatrian (Eds.), Electrocorticography: Current Trends and Future Perspectives, Elsevier, 1998, pp. 70-76.
11. Cascino G.D., So E.L., Sharbrough F.W., Strelow D., lagerlund T.D., Milde L.N., O'Brien P.C. Alfentanil-induced epileptiform activity in patients with partial epilepsy. J. Clin. Neurophysiol. 10(4):1993;520-525.
12. Chavkin C., Bakhit C., Weber E., Bloom F.E. Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus. Proc. Natl. Acad. Sci. U.S.A. 80:1983;7669-7673.
13. Chavkin C., Shoemaker W.J., McGinty J.F., Bayon A., Bloom F.E. Characterization of the prodynorphin and proenkephalin neuropeptide systems in rat hippocampus. J. Neurosci. 5:1985;808-816.
14. Chugani H.T., Ackermann R.F., Chugani D.C., Engel J.J. Opioid-induced epileptogenic phenomena: anatomical, behavioral, and electroencephalographic features. Ann. Neurol. 15:1984;361-368.
15. Cohen G.A., Doze V.A., Madison D.V. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron. 9:1992;325-335.
16. Cowan A., Tortella F.C., Adler M.W. A comparison of the anticonvulsant effects of two systemically active enkephalin analogues in rats. Eur. J. Pharmacol. 71:1981;117-121.
17. M.S. Duchowny, A.S. Harvey, M.R. Sperling, P.D. Williamson, Indications and criteria for surgical interventions, in: J.J. Engel, T.A. Pedley (Eds.), Epilepsy: A Comprehensive Textbook, Lippincott-Raven, Philadelphia, 1997, pp. 1677-1685.
18. Engel J.J., Ackermann R.F., Caldecott-Hazard S., Chugani H.T. Patterns of human local cerebral glucose metabolism during epileptic seizures. Science. 218:1982;64-66.
19. Fiol M.E., Torres F., Gates J.R., Maxwell R. Methohexital (Brevital) effect on electrocorticogram may be misleading. Epilepsia. 31:1990;524-528.
20. Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non opiate systems. Brain Res. Rev. 6:1983;197-210.
21. Frenk H., Engel J.J., Ackermann R.F.et al. Endogenous opioids may mediate postictal behavioral depression in amygdaloid-kindled rats. Brain Res. 167:1979;435-440.
22. Frost J.J.et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann. Neurol. 23:1988;231-237.
23. Gall C.M., Brecha H.J., Karten H., Chang K. Localization of enkephalin-like immunoreactivity to identified axonal and neuronal populations of the rat hippocampus. J. Comp. Neurol. 198:1981;335-350.
24. Ghazy A., Lundervold A., Veger T. Combined activation of the EEG with brietal and pentetrazol. Clin. Electroencephalogr. 9(2):1978;60-68.
25. Gioanni Y., Greco B., Prevost J. Search for the structures initiating seizures triggered by intraventricular injection of the mu opioid agonist dermorphin in rats. Epilepsia. 36(9):1995;922-928.
26. P. Gloor, Temporal sclerosis: historical background and an overview from a modern perspective, in: H.O. Luders (Ed.), Epilepsy Surgery, Raven Press, NY, 1991, pp. 689-703.
27. Goroszeniuk T., Albin M., Jones R.M. Generalized grand mal seizure after recovery from uncomplicated fentanyl-etomidate anesthesia. Anesth. Analg. 65(9):1986;979-981.
28. Gruol D.L., Chavkin C., Valentino R.J., Siggins G.R. Dynorphin A alters the excitability of pyramidal neurons of the rat hippocampus in vitro. Life Sci. 1:1983;533-536.
29. Hardiman O., Coughlan A., O'Moore B., Phillips J., Staunton H. Interictal spike localization with methohexitone: preoperative activation and surgical follow-up. Epilepsia. 28(4):1987;335-339.
30. Harris R., Paul R. The use of methohexitone in electrocorticography. Electroencephalogr. Clin. Neurophysiol. 27:1969;333-334.
31. Harrison M.B., Shumate M.D., Lothman E.W. Opioid peptide expression in models of chronic temporal lobe epilepsy. Neuroscience. 65(3):1995;785-795.
32. Ho S.S., Berkovic S.F., McKay W.J., Kalnins R.M., Bladin P.F. Temporal lobe epilepsy subtypes: differential patterns of cerebral perfusion on ictal SPECT. Epilepsia. 37(8):1996;788-795.
33. Holaday J.W., Belenky G.L. Opiate-like effects of electroconvulsive shock in rats: a differential effect of naloxone on nociceptive measures. Life Sci. 27:1980;1929-1938.
34. Holmes M.D., Wlensky A.J., Ojemann G.A., Ojemann L.M. Hippocampal or neocortical lesions on magnetic resonance imaging do not necessarily indicate site of ictal onsets in partial epilepsy. Ann. Neurol. 45:1999;461-465.
35. Houser C.R., Miyashiro J.E., Swartz B.E., Walsh G.O., Rich J.R., Delgado-Escueta A.V. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J. Neurosci. 10(1):1990;267-282.
36. Hsieh J.C., Shih Y.S., Hwang L.D., Lui P.K., Lui P.W., Lee T.Y., Yao C.S., Su M.S., Chung K.P. Activation of epileptogenic activities by etomidate in electrocorticoencephalography (ECoG) during operation for epilepsy. Ma Tsui Hsueh Tsa Chi. 28(2):1990;127-135.
37. Hufnagel A., Burr W., Elger C.E., Nadstawek J., Hefner C. Localization of the epileptic focus during methohexital-induced anesthesia. Epilepsia. 33:1992;271-284.
38. Isokawa-Akesson M., Wilson C.L., Babb T.L. Inhibition in synchronously firing human hippocampal neurons. Epilepsy Res. 3:1989;236-247.
39. Kearse L.A.J., Koski G., Husain M.V., Philbin D.M., McPeck K. Epileptiform activity during opioid anesthesia. Electroencephalogr. Clin. Neurophysiol. 87:1993;374-379.
40. Keene D.L., Roberts D., Splinter W.M., Higgins M., Ventureyra E. Alfentanil mediated activation of epileptiform activity in the electrocorticogram during resection of epileptogenic foci. Can. J. Neurol. Sci. 24(1):1997;37-39.
41. Kirchberger K., Schmitt H., Hummel C., Peinemann A., Pauli E., Kettenmann B., Stefan H. Clonidine and methohexital-induced epileptic discharges in patients with focal epilepsies. Epilepsia. 39(8):1998;841-849.
42. Kofke W.A., Garman R.H., Tom W.C., Rose M.E., Hawkins R.A. Alfentanil-induced hypermetabolism, seizure, and histopathology in rat brain. Anesth. Analg. 75:1992;953-964.
43. Linseman M.A., Corrigall W.A. Effects of morphine on CA1 versus dentate hippocampal field potentials following systemic administration in freely-moving rats. Neuropharmacology. 21:1982;361-366.
44. Manninen P.H., Burke S.J., Wennberg R., Lozano A.M., El Beheiry H. Intraoperative localization of an epileptogenic focus with alfentanil and fentanyl. Anesth. Analg. 88:1999;1101-1106.
45. Marco P., Sola R.G., Pulido P., Alijarde M.T., Sanchez A., Ramon y Cajal S., DeFelipe J. Inhibitory neurons in the human epileptogenic temporal neocortex. Brain. 119:1996;1327-1347.
46. G.W. Mathern, T.L. Babb, D.L. Armstrong, Hippocampal sclerosis, in: J.J. Engel, T.A. Pedley (Eds.), Epilepsy: A Comprehensive Textbook, Lippincott-Raven, Philadelphia, 1997, pp. 133-155.
47. Mayberg H.S.et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann. Neurol. 30:1991;3-11.
48. McGinty J.F., Henriksen S.J., Goldstein A., Terenius L., Bloom F.E. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 80:1983;589-593.
49. H.J. Meencke, G. Veith, Hippocampal sclerosis in epilepsy, in: H.O. Luders (Ed.), Epilepsy Surgery, Raven Press, NY, 1991, pp. 705-715.
50. Moore S.D., Madamba S.G., Schweitzer P., Siggins G.R. Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. J. Neurosci. 14(2):1994;809-820.
51. Paul R., Harris R.A. Comparison of methohexital and thiopentone in electrocorticography. J. Neurol. Neurosurg. Psychiatry. 33:1970;100-104.
52. Penfield W. Epileptogenic lesions. Acta Neurol. Psychiatr. Belg. 2:1956;75-88.
53. Przewlocka B., Machelska H., Lason W. Kappa opioid receptor agonists inhibit pilocarpine-induced seizures and toxicity in the mouse. Eur. Neuropsychopharmacol. 4:1994;527-533.
54. Rao T.L., Mummaneni N., El-Etr A.A. Convulsions: an unusual response to intravenous fentanyl administration. Anesth. Analg. 61(12):1982;1020-1021.
55. Rasmussen T.B. Surgical treatment of complex partial seizures: results, lessons, and problems. Epilepsia. 24(Suppl 1):1983;S65-S76.
56. Safwat A.M., Daniel D. Grand mal seizure after fentanyl administration. Anesthesiology. 59(1):1983;78.
57. Schiller Y., Cascino G.D., Sharbrough F.W. Chronic intracranial EEG monitoring for localizing the epileptogenic zone: an electroclinical correlation. Epilepsia. 39(12):1998;1302-1308.
58. Sloviter R.S., Sollas A.L., Barbaro N.M., Laxer K.D. Calcium binding protein and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J. Comp. Neurol. 308:1991;381-396.
59. Smith N.T., Benthuysen J.L., Bickford R.G.E.A. Seizures during opioid anesthesia induction: are they opioid-induced rigidity? Anesthesiology. 71:1989;852-862.
60. Snead O.C., Bearden L.J. Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin. Science. 210:1980;1031-1033.
61. Snead O.C.I. Opioid-induced seizures: a study of mu and delta specific mechanisms. Exp. Neurol. 93:1986;348-358.
62. Snead O.C.I., Bearden L.J. The epileptogenic spectrum of opiate agonists. Neuropharmacology. 21:1982;1137-1144.
63. D. Spencer, G. Ojemann, Overview of the therapeutic procedures, in: J.J. Engel (Ed.), Surgical Treatment of the Epilepsies, Raven Press, New York, 1993, pp. 455-471.
64. Spencer S.S. Depth electroencephalography in selection of refractory epilepsy for surgery. Ann. Neurol. 9(1981):1981;207-214.
65. Spencer S.S. Selection of patients for invasive monitoring. Ann. Neurol. 9:1981;207-214.
66. S.S. Spencer, M.R. Sperling, D.A. Shewmon, Intracranial electrodes, in: J.J. Engel, T.A. Pedley (Eds.), Epilepsy: A Comprehensive Textbook, Lippincott-Raven, Philadelphia, 1997, pp. 219-234.
67. Strong W.E., Matson M. Probable seizure after alfentanil. Anesth. Analg. 68:1989;692-693.
68. Sugita S., North R.A. Opioid actions on neurons of rat lateral amygdala in vitro. Brain Res. 612:1993;151-155.
69. Templehoff R., Modica P.A., Bernardo K.L., Edwards I. Fentanyl-induced electrocorticographic seizures in patients with complex partial epilepsy. J. Neurosurg. 77:1992;201-208.
70. Tortella F.C., Cowan A., Belenky G.L., Holaday J.W. Opiate-like electroencephalographic and behavioral effects of electroconvulsive shock in rats. Eur. J. Pharmacol. 76:1981;121-128.
71. Urca G., Frenk H. Pro- and anticonvulsant action of morphine in rats. Pharmacol. Biochem. Behav. 13:1980;343-347.
72. Werz M.A., Macdonald R.L. Opiate alkaloids antagonize postsynaptic glycine and GABA responses. Brain Res. 236:1982;107-119.
73. H.G. Wieser, P.D. Williamson, Ictal semiology, in: J.J. Engel (Ed.), Surgical Treatment of the Epilepsies, Raven Press, New York, 1993, pp. 161-172.
74. Wilder B.J. Activation of epileptic foci in psychomotor epilepsy. Epilepsia. 10:1969;418.
75. P.D. Williamson, J.J. Engel, C. Munari, Anatomic Classification of localization-related epilepsies, in: J.J. Engel, T.A. Pedley (Eds.), Epilepsy: A Comprehensive Textbook, Lippincott-Raven Publishers, Philadelphia, 1997, pp. 2405-2416.
76. Wyler A.R., Richey E.T., Atkinson R.A., Hermann B.P. Methohexital activation of epileptogenic foci during acute electrocorticography. Epilepsia. 28:1987;490-494.
77. Zhang L., Zhang Y., Wennberg R. Multiple actions of methohexital on hippocampal CA1 and cortical neurons of rat brain slices. J. Pharmacol. Exp. Ther. 286(3):1998;1177-1182.
78. Zieglgansberger W., French E.D., Siggins G.R., Bloom F. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science. 205:1980;415-417.